Piper Sandler’s revised price target sees shares of Oscar Health soaring 49%.
Broadcom gets a price target hike from Goldman ahead of earnings next month
Goldman Sachs sees shares of Broadcom rising 13% from here.
Nvidia shares hit by report on new AI chip competition. How worried should investors be?
Competition for Nvidia’s crown in the artificial intelligence is ramping up, but analysts aren’t too worried — for now.
These stocks well liked by analysts have not panned out in 2025
Some stocks with “buy” ratings from analysts have seen their shares, earnings and income sink this year.
This organ transport stock is breaking out. Where it might go, according to the charts
Todd Gordon goes through the technicals of the health care sector and this organ transport stock.
Investors can grab solid yield in this corner of the muni market, says Nuveen
As Americans shop for the holidays, the sales taxes collected are used to secure sales-tax bonds.
Dan Ives’ top tech picks into year-end
The Wedbush Securities analyst highlighted Microsoft, Nvidia and Tesla as names that will continue driving the AI revolution.
Michael Burry’s next ‘Big Short’: An inside look at his analysis showing AI is a bubble
The investment world is “expecting far more economic importance out of this technology than is likely to be provided,” Burry’s associate portfolio manager said.
Citi upgrades Chili’s parent on younger guests flocking to brand, building long-term relevancy
Shares of Brinker International could rise 25% from here, said Citi analyst Jon Tower.
This semiconductor equipment maker is a buy as Wall Street underappreciates China demand, says UBS
The bank upgraded the semiconductor equipment maker to buy from neutral.